Taysha Gene Therapies (TSHA) had the highest return between July 28, 2023 and August 30, 2023 by a small-cap US stock, returning 416.5%.
| ASSET | DATE | % RETURN |
|---|---|---|
Taysha Gene Therapies (TSHA) | 7/28/2023 - 8/30/2023 | 416.54% |
Innoviz Technologies (INVZW) | 7/28/2023 - 8/30/2023 | 300% |
Akso Health Group ADR (AHG) | 7/28/2023 - 8/30/2023 | 234.26% |
Applied Opt (AAOI) | 7/28/2023 - 8/30/2023 | 139.69% |
Tango Therapeutics (TNGX) | 7/28/2023 - 8/30/2023 | 126.96% |
Neuropace (NPCE) | 7/28/2023 - 8/30/2023 | 110% |
Telesat (TSAT) | 7/28/2023 - 8/30/2023 | 98.65% |
Eos Energy Enterprises (EOSEW) | 7/28/2023 - 8/30/2023 | 81.65% |
Lifeway Foods (LWAY) | 7/28/2023 - 8/30/2023 | 77.15% |
Waldencast Acquisition (WALDW) | 7/28/2023 - 8/30/2023 | 73.47% |
Eton Pharmaceuticals (ETON) | 7/28/2023 - 8/30/2023 | 64.73% |
American Coastal Insurance (ACIC) | 7/28/2023 - 8/30/2023 | 59.22% |
Praxis Precision Medicines (PRAX) | 7/28/2023 - 8/30/2023 | 57.95% |
Fulcrum Therapeutics (FULC) | 7/28/2023 - 8/30/2023 | 56.51% |
Nextnav Acquisition (NN) | 7/28/2023 - 8/30/2023 | 53.34% |
GigaCloud Technology Inc Class A Ordinary Shares (GCT) | 7/28/2023 - 8/30/2023 | 52.35% |
Gyre Therapeutics (GYRE) | 7/28/2023 - 8/30/2023 | 51.35% |
Abacus Life (ABL) | 7/28/2023 - 8/30/2023 | 50.96% |
Eos Energy Enterprises (EOSE) | 7/28/2023 - 8/30/2023 | 50.45% |
Groupon (GRPN) | 7/28/2023 - 8/30/2023 | 50.39% |
Capricor Therapeutics (CAPR) | 7/28/2023 - 8/30/2023 | 49.66% |
Limbach (LMB) | 7/28/2023 - 8/30/2023 | 46.55% |
Precigen (PGEN) | 7/28/2023 - 8/30/2023 | 45.67% |
Upwork (UPWK) | 7/28/2023 - 8/30/2023 | 45.24% |
Capri (CPRI) | 7/28/2023 - 8/30/2023 | 43.99% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
